• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鬼臼毒素衍生物 5p 双重抑制拓扑异构酶 II 和微管克服癌症多药耐药性。

Dual inhibition of topoisomerase II and microtubule of podophyllotoxin derivative 5p overcomes cancer multidrug resistance.

机构信息

Department of Oncology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tiantan Xili, 100050, Beijing, China.

HTA Co., Ltd., CAEA Center of Excellence on Nuclear Technology Applications for Engineering and Industrialization of Radiopharmaceuticals, CNNC Engineering Research Center of Radiopharmaceuticals, 102413, Beijing, China.

出版信息

Eur J Pharmacol. 2024 Nov 15;983:176968. doi: 10.1016/j.ejphar.2024.176968. Epub 2024 Sep 2.

DOI:10.1016/j.ejphar.2024.176968
PMID:39233039
Abstract

Compound 5p is a 4β-N-substituted podophyllotoxin derivative, which exhibited potent activity toward drug-resistant K562/A02 cells and decreased MDR-1 mRNA expression. Here, we further investigated its detail mechanism and tested its antitumor activity. 5p exerted catalytic inhibition of topoisomerase IIα, and didn't show the inhibitor of topoisomerase I. 5p exhibited the inhibitory effect on microtubule polymerization. 5p showed potent anti-proliferation against breast cancer, oral squamous carcinoma, and their drug-resistant cell lines, with resistance index of 0.61 and 0.86, respectively. 5p downregulated the expression levels of P-gp in KB cells and BCRP in MCF7/ADR cells in dose-dependent manner. Moreover, 5p induced KB and KB cells arrest at G/M phase by up-regulating the expression of γ-H2AX, p-Histone H3 and cyclin B1. 5p induced apoptosis and pyroptosis by increased the expression levels of cleaved-PARP, cleaved-caspase3, N-GSDME as well as LDH release in KB and KB cells. In addition, 5p efficiently impaired tumor growth in KB and KB xenograft mice. Conclusively, this work elucidated the dual inhibitor of topoisomerase II and microtubule of 5p and its mechanism of overcoming the multidrug resistance, indicating that 5p exerts the antitumor potentiality.

摘要

化合物 5p 是一种 4β-N-取代的鬼臼毒素衍生物,对耐药 K562/A02 细胞具有很强的活性,并降低了 MDR-1 mRNA 的表达。在这里,我们进一步研究了它的详细机制,并测试了它的抗肿瘤活性。5p 对拓扑异构酶 IIα 具有催化抑制作用,而对拓扑异构酶 I 没有抑制作用。5p 对微管聚合有抑制作用。5p 对乳腺癌、口腔鳞状细胞癌及其耐药细胞系表现出强烈的增殖抑制作用,其耐药指数分别为 0.61 和 0.86。5p 以剂量依赖的方式下调 KB 细胞中 P-gp 和 MCF7/ADR 细胞中 BCRP 的表达水平。此外,5p 通过上调 γ-H2AX、p-Histone H3 和 cyclin B1 的表达,使 KB 和 KB 细胞阻滞在 G/M 期。5p 通过增加 cleaved-PARP、cleaved-caspase3、N-GSDME 的表达水平以及 LDH 的释放,诱导 KB 和 KB 细胞发生凋亡和焦亡。此外,5p 有效地抑制了 KB 和 KB 异种移植小鼠的肿瘤生长。总之,这项工作阐明了 5p 作为拓扑异构酶 II 和微管的双重抑制剂及其克服多药耐药的机制,表明 5p 具有抗肿瘤潜力。

相似文献

1
Dual inhibition of topoisomerase II and microtubule of podophyllotoxin derivative 5p overcomes cancer multidrug resistance.鬼臼毒素衍生物 5p 双重抑制拓扑异构酶 II 和微管克服癌症多药耐药性。
Eur J Pharmacol. 2024 Nov 15;983:176968. doi: 10.1016/j.ejphar.2024.176968. Epub 2024 Sep 2.
2
CIP-36, a novel topoisomerase II-targeting agent, induces the apoptosis of multidrug-resistant cancer cells in vitro.CIP-36,一种新型拓扑异构酶 II 靶向剂,可诱导体外多药耐药癌细胞凋亡。
Int J Mol Med. 2015 Mar;35(3):771-6. doi: 10.3892/ijmm.2015.2068. Epub 2015 Jan 14.
3
5k, a novel β-O-demethyl-epipodophyllotoxin analogue, inhibits the proliferation of cancer cells in vitro and in vivo via the induction of G2 arrest and apoptosis.5k,一种新型的β-O-去甲基表鬼臼毒素类似物,通过诱导 G2 期阻滞和细胞凋亡,在体外和体内抑制癌细胞的增殖。
Invest New Drugs. 2011 Oct;29(5):786-99. doi: 10.1007/s10637-010-9423-5. Epub 2010 Mar 30.
4
Adva-27a, a novel podophyllotoxin derivative found to be effective against multidrug resistant human cancer cells.Adva-27a,一种新型鬼臼毒素衍生物,被发现对多药耐药的人类癌细胞有效。
Anticancer Res. 2012 Oct;32(10):4423-32.
5
One-pot synthesis of podophyllotoxin-thiourea congeners by employing NH₂SO₃H/NaI: Anticancer activity, DNA topoisomerase-II inhibition, and apoptosis inducing agents.利用氨基磺酸/碘化钠一锅法合成鬼臼毒素-硫脲类似物:抗癌活性、DNA拓扑异构酶-II抑制作用及凋亡诱导剂
Bioorg Med Chem Lett. 2015 Oct 1;25(19):4239-44. doi: 10.1016/j.bmcl.2015.07.100. Epub 2015 Aug 6.
6
A novel podophyllotoxin derivative (YB-1EPN) induces apoptosis and down-regulates express of P-glycoprotein in multidrug resistance cell line KBV200.一种新型鬼臼毒素衍生物(YB-1EPN)诱导多药耐药细胞系 KBV200 凋亡并下调 P-糖蛋白表达。
Eur J Pharmacol. 2010 Feb 10;627(1-3):69-74. doi: 10.1016/j.ejphar.2009.10.056. Epub 2009 Oct 30.
7
A Promising Microtubule Inhibitor Deoxypodophyllotoxin Exhibits Better Efficacy to Multidrug-Resistant Breast Cancer than Paclitaxel via Avoiding Efflux Transport.一种有前途的微管抑制剂脱氧鬼臼毒素通过避免外排转运比紫杉醇对多药耐药乳腺癌更有效。
Drug Metab Dispos. 2018 May;46(5):542-551. doi: 10.1124/dmd.117.079442. Epub 2018 Mar 9.
8
4β-amidotriazole linked podophyllotoxin congeners: DNA topoisomerase-IIα inhibition and potential anticancer agents for prostate cancer.4β-酰胺基三唑连接的鬼臼毒素类似物:DNA 拓扑异构酶-IIα 抑制和前列腺癌的潜在抗癌药物。
Eur J Med Chem. 2018 Jan 20;144:595-611. doi: 10.1016/j.ejmech.2017.12.050. Epub 2017 Dec 14.
9
Synthesis and evaluation of novel podophyllotoxin derivatives as potential antitumor agents.新型鬼臼毒素衍生物作为潜在抗肿瘤药物的合成与评价
Eur J Med Chem. 2014 Oct 6;85:498-507. doi: 10.1016/j.ejmech.2014.08.006. Epub 2014 Aug 4.
10
A polypeptide based podophyllotoxin conjugate for the treatment of multi drug resistant breast cancer with enhanced efficiency and minimal toxicity.一种基于多肽的鬼臼毒素缀合物,用于治疗多药耐药乳腺癌,具有增强的疗效和最小的毒性。
Acta Biomater. 2018 Jun;73:388-399. doi: 10.1016/j.actbio.2018.04.016. Epub 2018 Apr 22.